ANXA5 and central nervous system cancer: The amplified expressions of ANXA5 (Figures 2B, C), FKBP10 (Figures 2D, E), MSN (Figures 2F, G), and PYGL (Figures 2H, I) were correlated with favorable prognosis OS and DFS of glioma, which exert pivotal roles in glioma development and progression.